Khaled Nasr's Net Worth

$747 Million

Who is Khaled Nasr?

Khaled Nasr has an estimated net worth of $747 Million. This is based on reported shares across multiple companies, which include CORGENTECH INC, AVEDRO INC, TESARO, Inc., EnteroMedics Inc, Doximity, Inc., Invuity, Inc., Trius Therapeutics Inc, PMV Pharmaceuticals, Inc., GLAUKOS Corp, Braze, Inc., Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Venus Concept Inc., and Transcept Pharmaceuticals Inc.

SEC CIK

Khaled Nasr's CIK is 0001276600

Past Insider Trading and Trends

2014 was Khaled Nasr's most active year for acquiring shares with 32 total transactions. Khaled Nasr's most active month to acquire stocks was the month of January. 2014 was Khaled Nasr's most active year for disposing of shares, totalling 27 transactions. Khaled Nasr's most active month to dispose stocks was the month of April. 2010 saw Khaled Nasr paying a total of $9,397,557.48 for 3,548,643 shares, this is the most they've acquired in one year. In 2021 Khaled Nasr cashed out on 62,836,091 shares for a total of $174,791,472.50, their largest year based on trade value.